NYSE:MED Medifast (MED) Stock Price, News & Analysis $14.28 +0.71 (+5.22%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$14.29 +0.01 (+0.08%) As of 04:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Medifast Stock (NYSE:MED) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Medifast alerts:Sign Up Key Stats Today's Range$13.67▼$14.4250-Day Range$12.77▼$15.2252-Week Range$11.57▼$21.98Volume224,160 shsAverage Volume197,680 shsMarket Capitalization$156.92 millionP/E Ratio44.62Dividend YieldN/APrice Target$16.50Consensus RatingHold Company Overview Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland. Read More Medifast Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks73rd Percentile Overall ScoreMED MarketRank™: Medifast scored higher than 73% of companies evaluated by MarketBeat, and ranked 69th out of 146 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingMedifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageMedifast has received no research coverage in the past 90 days.Read more about Medifast's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth200.00% Earnings GrowthEarnings for Medifast are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 44.62, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.44.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 44.62, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 18.72.Price to Book Value per Share RatioMedifast has a P/B Ratio of 0.74. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Medifast's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted21.87% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 9.8.Change versus previous monthShort interest in Medifast has recently increased by 2.69%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMedifast does not currently pay a dividend.Dividend GrowthMedifast does not have a long track record of dividend growth. Sustainability and ESG2.0 / 5Environmental Score-4.00 Percentage of Shares Shorted21.87% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 9.8.Change versus previous monthShort interest in Medifast has recently increased by 2.69%, indicating that investor sentiment is decreasing. News and Social Media2.5 / 5News SentimentN/A News SentimentMedifast has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 1 news article for Medifast this week, compared to 3 articles on an average week.Search Interest6 people have searched for MED on MarketBeat in the last 30 days. This is an increase of 500% compared to the previous 30 days.MarketBeat Follows2 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,003.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 2.90% of the stock of Medifast is held by insiders.Percentage Held by Institutions95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Medifast's insider trading history. Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address MED Stock News HeadlinesWhy Medifast (MED) Stock Is Trading Up TodayAugust 23 at 2:55 AM | finance.yahoo.com2 Safe-and-Steady Stocks for Long-Term Investors and 1 We Brush OffAugust 15, 2025 | msn.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. | Brownstone Research (Ad)MED Q2 Deep Dive: Ongoing Coach Decline and GLP-1 Integration Shape OutlookAugust 14, 2025 | uk.finance.yahoo.comDole, B&G Foods, Medifast, USANA, and MGP Ingredients Shares Are Soaring, What You Need To KnowAugust 14, 2025 | msn.com5 Insightful Analyst Questions From Medifast’s Q2 Earnings CallAugust 13, 2025 | finance.yahoo.comMedifast (MED) Stock Trades Up, Here Is WhyAugust 12, 2025 | msn.comMedifast’s Earnings Call: Challenges and OptimismAugust 8, 2025 | theglobeandmail.comSee More Headlines MED Stock Analysis - Frequently Asked Questions How have MED shares performed this year? Medifast's stock was trading at $17.62 at the beginning of 2025. Since then, MED stock has decreased by 19.0% and is now trading at $14.2780. How were Medifast's earnings last quarter? Medifast Inc (NYSE:MED) issued its quarterly earnings results on Monday, August, 4th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.22) by $0.26. The specialty retailer had revenue of $105.56 million for the quarter, compared to analysts' expectations of $96.10 million. Medifast had a net margin of 0.76% and a trailing twelve-month return on equity of 2.00%. Read the conference call transcript. Who are Medifast's major shareholders? Medifast's top institutional investors include Acadian Asset Management LLC (3.74%), Bank of America Corp DE (3.61%), Geode Capital Management LLC (2.31%) and American Century Companies Inc. (1.95%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY). Company Calendar Last Earnings8/04/2025Today8/24/2025Next Earnings (Estimated)11/03/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorConsumer Staples Industry FOOD - MISC/DIVERSIFIED Sub-IndustryPersonal Products Current SymbolNYSE:MED CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees870Year Founded1981Price Target and Rating Average Price Target for Medifast$16.50 High Price Target$16.50 Low Price Target$16.50 Potential Upside/Downside+15.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)$0.32 Trailing P/E Ratio44.62 Forward P/E Ratio28.00 P/E GrowthN/ANet Income$2.09 million Net Margins0.76% Pretax Margin1.30% Return on Equity2.00% Return on Assets1.50% Debt Debt-to-Equity RatioN/A Current Ratio4.47 Quick Ratio3.82 Sales & Book Value Annual Sales$602.46 million Price / Sales0.26 Cash Flow$2.93 per share Price / Cash Flow4.87 Book Value$19.21 per share Price / Book0.74Miscellaneous Outstanding Shares10,990,000Free Float10,672,000Market Cap$156.92 million OptionableOptionable Beta0.80 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NYSE:MED) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.